Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Neonc Technologies, Inc.
Neonc Technologies, Inc.
Tianjin Medical University Cancer Institute and Hospital
University of Pittsburgh
University of Kentucky
Latin American Cooperative Oncology Group
Fundación GECP
Blueprint Medicines Corporation
Hoosier Cancer Research Network
Albert Einstein College of Medicine
Sun Yat-sen University